ReviewDermatologie (Heidelberg, Germany)2026
[Focal epithelial hyperplasia-Heck's disease].
Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Focal epithelial hyperplasia (FEH), also known as Heck's disease, is a rare, benign condition of the oral mucosa. It is characterized by multiple, soft, skin-colored or whitish papules or flat nodules that occur primarily on the mucosa of the lips, cheeks, and tongue. The prevalence of this condition is particularly high among indigenous populations of Central and South America, leading to some discussion of a genetic predisposition in addition to familial transmission. However, the number of reported cases from all parts of the world is currently increasing, particularly from Europe. FEH occurs primarily in children and adolescents, but older adults are also affected. Infection with human papillomavirus (HPV) types HPV13 or HPV32 has been identified as the cause of FEH. A definitive diagnosis of Heck's disease based on clinical presentation, histology, and HPV genotyping, as well as the differential diagnosis to rule out other oral manifestations allow for a conservative treatment approach, as the causative HPV types do not have oncogenic potential and the lesions often resolve spontaneously.
Indexed as
Identifiers
42754675What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.